SubtypeDrug: a software package for prioritization of candidate cancer subtype-specific drugs

Xudong Han1, Qingfei Kong2, Chonghui Liu2

  • 1College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China.

Abstract

Insights

SubtypeDrug prioritizes cancer-subtype-specific drugs using R, analyzing molecular data to identify targeted therapies. This system biology approach aids personalized cancer medicine by revealing drugs effective for specific cancer subtypes.

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Genomics

Background:

  • Cancer heterogeneity necessitates subtype-specific treatments for effective personalized medicine.
  • Existing tools often lack the granularity to identify drugs tailored to specific cancer subtypes.

Purpose of the Study:

  • To develop a novel R-based software package, SubtypeDrug, for prioritizing cancer-subtype-specific drugs.
  • To enable identification of drugs targeting specific molecular or histological cancer subtypes.

Main Methods:

  • SubtypeDrug utilizes a systems biology approach, analyzing cancer expression data.
  • It identifies dysregulated subpathways and infers sample-specific activity profiles.
  • Drug-disease reverse association is evaluated at the subpathway level.

Main Results:

  • SubtypeDrug successfully identifies cancer-subtype-specific drugs by analyzing expression data.
  • The software enables prioritization of drugs based on subpathway-level biological functions.
  • It facilitates a novel approach to drug discovery for tailored cancer treatments.

Conclusions:

  • SubtypeDrug offers a novel computational approach to identify subtype-specific drugs, addressing limitations of current tools.
  • This R package supports the development of personalized medicine by facilitating tailored cancer treatments.
  • SubtypeDrug aids in discovering drugs effective for distinct cancer subtypes, advancing precision oncology.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.1K
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.5K